IPD GROUP LIMITED

Other languages IPD Group Limited

Equities

IPG

AU0000189318

Market Closed - Australian S.E. Other stock markets 02:10:22 2024-05-29 am EDT			5-day change	1st Jan Change
4.53 ^AUD	+3.66%		+5.59%	-6.02%

Apr. 30	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
Apr. 17	Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	Apr. 29
Impedimed Names Independent Non-Executive Chair	Feb. 27
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	Feb. 26
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	Feb. 14
ImpediMed CEO, CFO Step Down; Shares Fall 11%	Nov. 19
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	Nov. 02
Vaxcyte Says FDA Approves Investigational New Drug Application for Invasive Pneumococcal Disease Vaccine Candidate	23-10-19
ImpediMed Appoints Medical Chief; Shares Down 3%	23-09-26
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	23-08-31
US FDA Gives Clearance to Impedimed's BIS System SOZO Pro	23-05-04
Impedimed's Bioimpedance Spectroscopy Platform Gets Boost Following US Cancer Network Guideline Update	23-03-27
Blackbird annual loss narrows as revenue rises, starts 2023 "strongly"	23-03-22
STMicroelectronics : dans le Top 100 Global Innovator 2023	23-02-17
IPD Expands Services Offering with Acquisition of Electric Vehicle Charging Firm	22-04-05
IPD Group Limited Reaffirms Group Earnings Guidance for the Fiscal Year 2022	22-02-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer